drug
ranibizumab SR
Marketedupdated 3mo agoby Genentech Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- tagApproval18 co-mentions · 9 sources
- drugBYOOVIZ16 co-mentions · 8 sources
- drugranibizumab14 co-mentions · 14 sources
- drugranibizumab biosimilar13 co-mentions · 13 sources
- companySamsung Bioepis Co Ltd8 co-mentions · 8 sources
- companyXbrane Biopharma AB5 co-mentions · 5 sources
- tagOphthalmology5 co-mentions · 5 sources
- tagBiosimilar5 co-mentions · 5 sources
all catalysts(0)
nothing on the calendar yet
Trials studying ranibizumab SR
- phase2Study of Zifibancimig in Participants With Neovascular Age-related Macular Degeneration
- phase2Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD
- phase3A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
- phase3A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)
- phase3A Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Choroidal Neovascularization Secondary to Pathologic Myopia
- phase3Extension Study for the Port Delivery System With Ranibizumab (Portal)
- phase3Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
- phase2A Study to Investigate Vamikibart (RO7200220) in Diabetic Macular Edema
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1m ago
Found something off?
comments(0)
5-min edit window · permanent after that